{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:33:19Z","timestamp":1787790799981,"version":"build-2784847793"},"reference-count":16,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T00:00:00Z","timestamp":1728000000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RF-2016-023617571"],"award-info":[{"award-number":["RF-2016-023617571"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.cmi.2024.09.024","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:54:43Z","timestamp":1727398483000},"page":"121.e1-121.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Evaluating the efficacy of whole genome sequencing in predicting susceptibility profiles for first-line antituberculosis drugs"],"prefix":"10.1016","volume":"31","author":[{"given":"Arash","family":"Ghodousi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Omrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Torri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hedyeh","family":"Teymouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Vismara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Matteelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi Ruffo","family":"Codecasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela Maria","family":"Cirillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2024.09.024_bib1","series-title":"Tuberculosis action plan for the WHO European Region, 2023\u20132030","year":"2023"},{"key":"10.1016\/j.cmi.2024.09.024_bib2","series-title":"Global tuberculosis report 2023","year":"2023"},{"key":"10.1016\/j.cmi.2024.09.024_bib3","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41579-019-0214-5","article-title":"Whole genome sequencing of Mycobacterium tuberculosis: current standards and open issues","volume":"17","author":"Meehan","year":"2019","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.cmi.2024.09.024_bib4","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01163-2018","article-title":"Whole genome sequencing of Mycobacterium tuberculosis","volume":"52","author":"Cabibbe","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cmi.2024.09.024_bib5","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1056\/NEJMoa1800474","article-title":"Prediction of susceptibility to first-line tuberculosis drugs by DNA sequencing","volume":"379","author":"CRyPTIC Consortium and the 100,000 Genomes Project","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cmi.2024.09.024_bib6","series-title":"Technical Report on critical concentrations for drug susceptibility testing of medicines used in the treatment of drug-resistant tuberculosis","year":"2018"},{"key":"10.1016\/j.cmi.2024.09.024_bib7","doi-asserted-by":"crossref","first-page":"7519","DOI":"10.1038\/s41467-023-42755-9","article-title":"A\u00a0smooth tubercle bacillus from Ethiopia phylogenetically close to the Mycobacterium tuberculosis complex","volume":"14","author":"Yenew","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.cmi.2024.09.024_bib8","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.5895","article-title":"MTBseq: a comprehensive pipeline for whole genome sequence analysis of Mycobacterium tuberculosis complex isolates","volume":"6","author":"Kohl","year":"2018","journal-title":"PeerJ"},{"key":"10.1016\/j.cmi.2024.09.024_bib9","series-title":"Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance","year":"2023"},{"key":"10.1016\/j.cmi.2024.09.024_bib10","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02617-20","article-title":"Overcoming the challenges of pyrazinamide susceptibility testing in clinical Mycobacterium tuberculosis isolates","volume":"65","author":"Mok","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2024.09.024_bib11","article-title":"Phenotypic susceptibility testing of pyrazinamide in lineage 1 M.tuberculosis isolates\u2013a North London cohort experience","volume":"62","author":"Duff","year":"2023","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cmi.2024.09.024_bib12","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1128\/AAC.01916-20","article-title":"Atypical genetic basis of pyrazinamide resistance in monoresistant Mycobacterium tuberculosis","volume":"65","author":"Modlin","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2024.09.024_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.775030","article-title":"Application of next generation sequencing for diagnosis and clinical management of drug-resistant tuberculosis: Updates on recent developments in the field","volume":"13","author":"Dookie","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.cmi.2024.09.024_bib14","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02272-2020","article-title":"Use of a whole genome sequencing-based approach for Mycobacterium tuberculosis surveillance in Europe in 2017\u20132019: an ECDC pilot study","volume":"57","author":"Tagliani","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cmi.2024.09.024_bib15","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00387-2018","article-title":"Countrywide implementation of whole genome sequencing: an opportunity to improve tuberculosis management, surveillance and contact tracing in low incidence countries","volume":"51","author":"Cabibbe","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cmi.2024.09.024_bib16","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.3390\/microorganisms11071809","article-title":"The relative positioning of genotyping and phenotyping for tuberculosis resistance screening in two EU national reference laboratories in 2023","volume":"11","author":"Anthony","year":"2023","journal-title":"Microorganisms"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X24004567?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X24004567?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T22:53:17Z","timestamp":1738450397000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X24004567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1198743X24004567"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2024.09.024","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating the efficacy of whole genome sequencing in predicting susceptibility profiles for first-line antituberculosis drugs","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2024.09.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.","name":"copyright","label":"Copyright"}]}}